Elon Musk has said that he used ketamine as a treatment in the past, but he denied reports that he was taking it frequently ...

Mosanna Therapeutics, a biotech company rethinking treatment of obstructive sleep apnea (OSA), today announced the close of $80 million in Series A funding. The company is developing an easy-to-use ...

EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in Mosanna Therapeutics ("the Company"). The clinical-stage biotech company headquartered in Basel, Switzerland, is developing ...

While its effectiveness is still being researched, clinical therapists across the country and here at Bryan Medical say it’s mostly beneficial for treatment-resistant depression patients.

Opioid overdoses are a major public health issue in the U.S., killing tens of thousands of people every year. The medicine ...

The field is expanding quickly, and often without clear rules. Though the FDA has approved one ketamine-based nasal spray for depression, most clinics offer intravenous infusions of ketamine, an ...

And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to give rapid relief to depression ...

(NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, ...

The two seem to have paused their online war of words. But the president may sell his Tesla and has continued to criticize ...

I freaked out during the first few sessions, and each time different people took my blood pressure, and each time I told them ...

Elon Musk's use of ketamine sparks debate. He uses it for depression, but reports suggest excessive use. Ketamine use is ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...